3,738 results match your criteria Carcinoma in Situ of the Urinary Bladder


Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature.

Int J Surg Pathol 2019 Apr 8:1066896919839781. Epub 2019 Apr 8.

1 Robert-Bosch-Hospital, Stuttgart, Germany.

Mixed adenoneuroendocrine carcinomas are rare and usually occur in the gastrointestinal tract. Although there have been several investigations regarding their developmental mechanism, the molecular origin of these tumors remains unclear. In this article, we present an exceedingly rare case of a mixed tumor of the urinary bladder with an adenocarcinomatous and a neuroendocrine component and a concomitant urothelial carcinoma in situ (CIS). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1066896919839781DOI Listing
April 2019
1 Read

Concomitant primary ovarian paraganglioma neuroendocrinal differentiated urothelial tumor in a BOTOX-injected bladder: A case report.

Int J Surg Case Rep 2019 Mar 28;57:122-125. Epub 2019 Mar 28.

Urology Department, Urology and Nephrology Center, Mansoura University, Egypt.

Introduction: There is no reported data for patients with malignant bladder Botox injection related outcomes. Herein, we reported effect of Botox injection in case of BCG cystitis. In addition, reporting of rare incidence of both primary neuroendocrine differentiation of bladder tumor and primary ovarian paraganglioma post cystectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijscr.2019.03.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447811PMC
March 2019
1 Read

Urothelial Carcinoma Recurrence in an Orthotopic Neobladder without Urethral or Upper Urinary Tract Involvement.

Case Rep Urol 2019 5;2019:8458706. Epub 2019 Mar 5.

Department of Urology, Loyola University Medical Center, Maywood, IL, USA.

We describe a case of a 71-year-old male with an isolated recurrence of urothelial carcinoma in an ileal neobladder without involvement of the upper urinary tract or urethra. He was diagnosed with high grade urothelial carcinoma involving a bladder diverticulum with associated carcinoma in situ. He underwent a radical cystectomy and orthotopic Studer ileal neobladder. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/8458706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425315PMC
March 2019
2 Reads

Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma.

World J Urol 2019 Mar 26. Epub 2019 Mar 26.

Division of Urology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Purpose: To summarize knowledge on upper urinary tract carcinoma (UTUC) regarding diagnostic procedures, risk factors and prognostic markers.

Methods: A scoping review approach was applied to search literature in Pubmed, Web of Science, and Embase. Consensus was reached through discussions at Consultation on UTUC in Stockholm, September 2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-019-02732-8DOI Listing

Carcinoma In Situ of the Urinary Bladder: A Systematic Review of Current Knowledge Regarding Detection, Treatment, and Outcomes.

Eur Urol Focus 2019 Mar 22. Epub 2019 Mar 22.

Oncology Urology Unit, Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.

Context: Carcinoma in situ (CIS) of the bladder is defined as a high-grade flat lesion confined to the mucosa. Intravesical treatment with bacillus Calmette-Guérin (BCG) is commonly used to reduce the risk of recurrence and progression; however, CIS of the bladder exhibits a heterogeneous clinical behavior and a significant proportion of patients do not show a primary response.

Objective: To evaluate the available evidence concerning diagnosis, treatment strategies, follow-up, prognosis, and oncological outcomes in patients with CIS of the bladder. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.03.012DOI Listing

Distal Ureter Management During Nephroureterectomy: Evidence from a Systematic Review and Cumulative Analysis.

J Endourol 2019 Apr 28;33(4):263-273. Epub 2019 Mar 28.

2 Glasgow Urological Research Unit, Department of Urology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.

Introduction And Objectives: Standard of care in upper tract urothelial cancer is nephroureterectomy with bladder cuff excision (BCE). However, alternative techniques such as transurethral incision/resection have been used to simplify distal ureterectomy. The optimum strategy is unclear, and current guidelines do not specify a gold standard technique. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2018.0819DOI Listing
April 2019
2 Reads

Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.

Int J Mol Sci 2019 Feb 14;20(4). Epub 2019 Feb 14.

Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.

Diagnostic methods currently used for bladder cancer are cystoscopy and urine cytology. Cystoscopy is an invasive tool and has low sensitivity for carcinoma in situ. Urine cytology is non-invasive, is a low-cost method, and has a high specificity but low sensitivity for low-grade urothelial tumors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20040821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412916PMC
February 2019

Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.

Int Urol Nephrol 2019 Mar 31;51(3):435-441. Epub 2019 Jan 31.

Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

Purpose: To assess the impact of carcinoma in situ (CIS) on oncologic outcomes in patients who underwent radical cystectomy, with a focus on those who received neoadjuvant chemotherapy (NAC) including patients with down-staging to ≤ pT1cancer after chemotherapy.

Materials And Methods: All patients who underwent radical cystectomy for urothelial cancer with curative intent from 1985 to 2011 were included. The impact of CIS on recurrence free and overall survival (OS) was assessed in the whole cohort and a subgroup who received NAC as well as those with response to chemotherapy and down-staging to ≤ pT1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-019-02087-4DOI Listing
March 2019
3 Reads
1.293 Impact Factor

Positive Precystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder Substitution.

J Urol 2019 Jan 25:101097JU0000000000000034. Epub 2019 Jan 25.

Department of Urology, University Hospital of Bern, University of Bern , Bern , Switzerland.

Purpose: We investigated the influence of positive precystectomy biopsies of the prostatic urethra in males and the bladder neck in females on urethral recurrence, cancer specific and overall survival, and functional outcomes after orthotopic bladder substitution.

Materials And Methods: We retrospectively analyzed the records of 803 consecutive patients, including 703 males and 100 females, who underwent orthotopic bladder substitution as well as precystectomy biopsy of the prostatic urethra in males and the bladder neck in females, at our institution between April 1986 and December 2017.

Results: Precystectomy biopsies were negative in 755 of the 803 patients (94%) (group 1) and positive in 48 (6%) (group 2). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JU.0000000000000034DOI Listing
January 2019
1 Read

[Instillation therapies for urothelial carcinoma of the upper urinary tract].

Urologe A 2019 Jan;58(1):25-29

Urologische Universitätsklinik, Inselspital, Universitätsspital Bern, 3010, Bern, Schweiz.

Traditionally, urothelial carcinoma of the upper urinary tract was a clear indication for radical nephroureterectomy with bladder cuff excision. It has been shown that in well-selected patients and depending on tumor stage, a kidney-sparing approach can be pursued with good oncological outcome and equivalent to the radical approach. The prevention of local and bladder recurrences is an important factor. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00120-018-0830-0
Publisher Site
http://dx.doi.org/10.1007/s00120-018-0830-0DOI Listing
January 2019
8 Reads

[Organ preservation in cancer of the upper urinary tract].

Authors:
F Vom Dorp

Urologe A 2019 Jan;58(1):22-24

Helios Klinikum Duisburg, Grunewaldstraße 96, 47053, Duisburg, Deutschland.

Urothelial carcinoma of the upper urinary tract is a rare disease. Tumor biology is comparable to transitional cell carcinomas of the bladder. Local tumor control is much more difficult to achieve in the upper urinary tract than in the bladder. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00120-018-0831-zDOI Listing
January 2019
1 Read

Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment.

Scand J Urol 2018 Oct - Dec;52(5-6):377-384. Epub 2019 Jan 8.

a Cancer Theme, Patient Area Pelvic Cancer , Karolinska University Hospital , Stockholm , Sweden.

Objective: Investigate symptoms and how they affect daily life in patients with Non-Muscle Invasive Bladder Cancer (NMIBC) treated with Bacillus Calmette-Guérin (BCG) instillations.

Materials And Methods: Patients treated with BCG were included. After an initial transurethral resection (TURB) followed by a second-look resection, the patients were given an induction course with BCG for 6 weeks followed by maintenance therapy for 2 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21681805.2018.1538162DOI Listing
January 2019
5 Reads

Condyloma Acuminata Presenting as Isolated Papillary Lesions in the Prostatic Urethra.

Am J Case Rep 2018 Dec 22;19:1522-1525. Epub 2018 Dec 22.

Department of Pathology, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.

BACKGROUND A condyloma acuminatum is a sexually transmitted, human papillomavirus (HPV) associated, neoplasm. In men, it is predominantly found on external genitalia and rarely progresses more proximally than the distal penile urethra. Condyloma acuminata of the prostatic urethra are rare and are usually seen as an extension of, or in association with external lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/AJCR.911682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320550PMC
December 2018
5 Reads

Editorial Comment.

Authors:
Georgios Gakis

J Urol 2019 01;201(1):54-55

Department of Urology and Pediatric Urology, University Hospital of Würzburg, Julius-Maximillians University, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000550123.08098.adDOI Listing
January 2019
1 Read

Editorial Comment.

J Urol 2019 01;201(1):54

Department of Urology, Ludwig-Maximilians-University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000550122.69979.70DOI Listing
January 2019
1 Read

The history of urologic pathology: an overview.

Histopathology 2019 Jan;74(1):184-212

Indiana University Medical Center, Indianapolis, IN, USA.

This article begins with the testis and a legendary figure, Sir Astley Cooper, who wrote an early text on the organ. The early 20th century saw the first major development, the description of the seminoma by the French investigator Maurice Chevassu, but the pace of knowledge did not accelerate until after World War II with a major article from the Armed Forces Institute of Pathology (AFIP) by Nathan B. Friedman and Robert A. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.13753
Publisher Site
http://dx.doi.org/10.1111/his.13753DOI Listing
January 2019
15 Reads

Precursor lesions of the urinary bladder.

Authors:
Jesse K McKenney

Histopathology 2019 Jan;74(1):68-76

Robert J. Tomsich Institute of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.

The classification of neoplastic precursor lesions in the urinary tract has evolved slowly with the gradual accumulation of clinicopathological data. Current nomenclature was codified most recently by the 2016 WHO classification, which is based on primary data with clinical outcome, consensus group statements and considerations of practical utility in routine diagnosis. This review discusses precursor lesions of urothelial, squamous and glandular lineage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13762DOI Listing
January 2019
5 Reads

Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system.

World J Urol 2018 Dec 10. Epub 2018 Dec 10.

Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea.

Purpose: To develop and validate novel nomograms to predict recurrence and progression after transurethral resection of bladder tumor (TURBT) in Korean patients with non-muscle-invasive bladder cancer (NMIBC).

Methods: We retrospectively analyzed the clinical data on 970 newly diagnosed NMIBC patients after TURBT between 2000 and 2013 in a single institution. We used multivariate Cox proportional hazard models to identify the significant predictors of recurrence and progression, which resulted in the construction of the nomograms predicting the 5-year probability of recurrence and progression. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00345-018-2581-3
Publisher Site
http://dx.doi.org/10.1007/s00345-018-2581-3DOI Listing
December 2018
13 Reads

Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion.

Am J Surg Pathol 2019 Apr;43(4):475-479

Departments of Pathology.

Benign urachal remnants can be encountered in the adult urinary bladder and it is recognized that these can uncommonly give rise to urachal urothelial carcinoma. However, urachal remnants containing urothelial carcinoma incidentally encountered in cystectomies for bladder cancer has not been previously described. Herein, we present 8 adult bladder cancer cystectomies with incidental urachal remnants containing urothelial carcinoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001192DOI Listing
April 2019
4 Reads

Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results.

Diagn Cytopathol 2019 Apr 12;47(4):282-288. Epub 2018 Nov 12.

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Background: We examine the performance of cytology and FISH in the detection of urothelial carcinoma (UC), and explore the reasons for discrepant results, and potential clinical implications.

Methods: Urine samples from 89 patients were prospectively collected for simultaneous cytology and UroVysion FISH, and results correlated with concurrent biopsies and/or clinical or histologic follow-up data. Corresponding tissue biopsies, where available, were also evaluated by FISH. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dc.24108DOI Listing
April 2019
2 Reads

Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma of the Urinary Bladder: A Retrospective Multicentre Study.

Bladder Cancer 2018 Oct 29;4(4):365-376. Epub 2018 Oct 29.

Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.

Objective: To examine the effect of intravesical radiofrequency-induced chemohyperthermia (RF-CHT) in carcinoma (CIS) patients overall and split according to previously received therapy.

Methods: CIS patients that underwent an induction and maintenance phase of≥6 RF-CHT instillations, and had either pathology or cystoscopy plus cytology available at 6 months of follow-up were retrospectively included. Complete response (CR), recurrences, cystectomy-free rate, overall survival (OS), and adverse events were evaluated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-180187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218119PMC
October 2018
1 Read

Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy.

Eur Urol Focus 2018 07 8;4(4):485-493. Epub 2018 Nov 8.

Unit of Dendritic Cell Immunobiology, Department of Immunology, Institut Pasteur, Paris, France; INSERM U1223, Institut Pasteur, Paris, France.

Context: More than 40 yr ago, bacillus Calmette-Guérin (BCG) was introduced as an adjuvant therapy following transurethral resection of papillary tumours and as a treatment for carcinoma in situ of the bladder. Some 30 yr after its introduction, BCG maintenance therapy was found to be superior to induction therapy alone, representing the most relevant clinical improvement to BCG therapy since its inception.

Objective: To review current efforts and future opportunities to improve BCG immunotherapy. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24054569183031
Publisher Site
http://dx.doi.org/10.1016/j.euf.2018.10.010DOI Listing
July 2018
9 Reads

Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer.

Urol Int 2019 1;102(1):77-82. Epub 2018 Nov 1.

Department of Urology, Caritas St. Josef Medical Centre, Regensburg University, Regensburg, Germany.

Background: Cancer/testis antigens (CTA) are expressed in urothelial bladder cancer (UBC). Their therapeutical and prognostic relevance remains unclear. We studied the correlation of MAGEA3 and CTAG1B with histopathological factors in UBC and their prognostic value. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/493577
Publisher Site
http://dx.doi.org/10.1159/000493577DOI Listing
March 2019
6 Reads

[The REVELA13 observatory to study new cases of bladder tumor among women living in Bouches-du-Rhône county].

Prog Urol 2018 Dec 10;28(16):935-941. Epub 2018 Oct 10.

Service d'urologie et de transplantation rénale, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France; Aix Marseille université, 13005 France.

Introduction: The REVELA13 observatory is a unique epidemiological tool listing the new cases of kidney tumors, bladder tumors and acute leukaemias in the Bouches-du-Rhône county (France). Aim was to exploit for the first time data from this observatory regarding new cases of bladder tumors≥T1 in women from 2012 to 2014.

Materials: This epidemiological study was observational and descriptive. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S11667087183052
Publisher Site
http://dx.doi.org/10.1016/j.purol.2018.09.004DOI Listing
December 2018
11 Reads

UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.

Oncol Rep 2018 Nov 10;40(5):2497-2506. Epub 2018 Sep 10.

Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles (ULB), B‑1070 Brussels, Belgium.

Non‑coding RNAs (ncRNAs) have been shown to serve important roles in carcinogenesis via complex mechanisms, including transcriptional and post‑transcriptional regulation, and chromatin interactions. Urothelial carcinoma‑associated 1 (UCA1), a long ncRNA, was recently shown to have tumorigenic properties in urothelial bladder cancer (UBC), as demonstrated by enhanced proliferation, migration, invasion and therapy resistance of UBC cell lines in vitro. These in vitro findings suggested that UCA1 is associated with aggressive tumor behavior and could have prognostic implications in UBC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2018.6697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151879PMC
November 2018
1 Read

Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder.

Curr Urol Rep 2018 Sep 13;19(11):94. Epub 2018 Sep 13.

Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Purpose Of Review: There are an estimated 33 million men and women with overactive bladder (OAB) in the USA. Despite the prevalence of OAB, it remains a frequently misdiagnosed condition. OAB has shared symptomatology with other common urologic conditions, namely recurrent urinary tract infections (UTIs). Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11934-018-0839-3
Publisher Site
http://dx.doi.org/10.1007/s11934-018-0839-3DOI Listing
September 2018
45 Reads

Nasopharyngeal carcinoma with unusual metastasis to urinary bladder.

J Cancer Res Ther 2018 Jul-Sep;14(5):1160-1161

Department of Histopathology and Cytopathology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini, New Delhi, India.

Nasopharyngeal carcinoma (NPC) metastasizing to urinary bladder is an uncommon site. We report an interesting case of NPC, on follow-up, presenting with unusual urinary symptoms and mimicking a primary bladder cancer. Subsequent bladder cold cup biopsy and immunohistochemistry unfolded a metastasis of NPC, highlighting unexpected and a rare presentation. Read More

View Article

Download full-text PDF

Source
http://www.cancerjournal.net/text.asp?2018/14/5/1160/204844
Publisher Site
http://dx.doi.org/10.4103/0973-1482.204844DOI Listing
October 2018
3 Reads

Diagnostic Advances in Urine Cytology.

Surg Pathol Clin 2018 Sep 13;11(3):601-610. Epub 2018 Jul 13.

Cleveland Clinic Foundation, Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Electronic address:

The utility of urine cytology has shifted from the identification of red blood cells, crystals, or parasites to its currently used role of detection of cancer cells exfoliated in urine samples. A variety of ancillary tests have been developed to complement the diagnostic ability of urine cytology. Furthermore, urine testing will continue to evolve as the pathogenesis of genitourinary tract diseases in depth is understood. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18759181183003
Publisher Site
http://dx.doi.org/10.1016/j.path.2018.06.001DOI Listing
September 2018
32 Reads

Prognostic Factors Related to Recurrence-Free Survival for Primary Carcinoma in situ of the Bladder after Bacillus Calmette-Guérin: A Retrospective Study.

Urol Int 2018 4;101(3):269-276. Epub 2018 Sep 4.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Introduction: Primary carcinoma in situ (P-CIS) of the bladder is rare and its clinical behavior and predictive features have not been well described. The purpose of this study was to evaluate the effects of various factors including angiotensin-2 converting enzyme inhibitors/angiotensin II receptor blockers (ACEIs/ARBs) on recurrence-free survival (RFS)-related prognosis in patients with P-CIS.

Materials And Methods: In our medical center, 5,945 patients were diagnosed with bladder cancer from January 1999 to January 2014. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000492121DOI Listing
April 2019
18 Reads

Educational Case: Bladder Carcinoma In Situ.

Authors:
H James Williams

Acad Pathol 2018 Jan-Dec;5:2374289517719858. Epub 2018 Aug 14.

Department of Pathology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV, USA.

The following fictional case is intended as a learning tool within the Pathology Competencies for Medical Education (PCME), a set of national standards for teaching pathology. These are divided into three basic competencies: Disease Mechanisms and Processes, Organ System Pathology, and Diagnostic Medicine and Therapeutic Pathology. For additional information, and a full list of learning objectives for all three competencies, see http://journals. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2374289517719858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096676PMC
August 2018
19 Reads

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?

PLoS One 2018 23;13(8):e0202965. Epub 2018 Aug 23.

Uropathology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.

Bladder cancer therapy relies on aggressive treatments highlighting the need for new, targeted therapies with reduced side effects. SWI/SNF complexes are mutated in ~20% across human cancers and dependency of SWI/SNF-deficient tumors on EZH2 has been uncovered recently. To systematically dissect the frequency of genetic alterations in SWI/SNF complexes potentially contributing to their inactivation, mutations and copy number variations in 25 SWI/SNF subunit genes were analyzed making use of publicly available sequencing data for 408 muscle-invasive bladder carcinoma samples. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202965PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107234PMC
February 2019
3 Reads

Diagnostic Value Comparison of Urothelium Carcinoma Among Urine Exfoliated Cells Fluorescent In Situ Hybridization (FISH) Examination, Computerized Tomography (CT) Scan, and Urine Cytologic Examination.

Med Sci Monit 2018 Aug 19;24:5788-5792. Epub 2018 Aug 19.

Department of Urinary Surgery, Hebei General Hospital, Shijiazhuang, Hebei, China (mainland).

BACKGROUND This study aimed to compare the clinical effectiveness of urine exfoliated cells FISH examination, CT scan, and urine cytologic examination on the diagnosis of upper urinary tract urothelium carcinoma with hematuresis symptom. MATERIAL AND METHODS A total of 30 patients with suspicious upper urinary tract urothelium carcinoma between Aug 2010 and Aug 2011 were enrolled, including 23 males and 7 females. All the subjects received urine exfoliated cells FISH examination, CT scan, and urine cytologic examination. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/MSM.910134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111772PMC
August 2018
4 Reads

Are there any metastases to the chest in non-muscle-invasive bladder cancer patients on follow-up computed tomography?

Int Urol Nephrol 2018 Oct 16;50(10):1771-1778. Epub 2018 Aug 16.

Department of Radiology, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan.

Purpose: The purpose of the study was to retrospectively determine whether there are metastases to the chest in patients with primary non-muscle-invasive urothelial carcinoma in the bladder on the follow-up computed tomography (CT).

Methods: We analyzed 328 patients with follow-up chest CT for urothelial carcinoma of the bladder diagnosed between January 2004 and September 2013. We divided patients into four groups: Ta (n = 74), T1 (n = 78), carcinoma in situ (CIS, n = 25), and ≥ T2 (n = 151). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-018-1952-4DOI Listing
October 2018
6 Reads

Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis.

J Urol 2019 01;201(1):46-53

Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.

Purpose: We investigated the prognostic impact of concomitant carcinoma in situ in radical cystectomy specimens.

Materials And Methods: We performed a systematic review and meta-analysis using MEDLINE®, Scopus®, Web of Science™ and The Cochrane Library to identify eligible studies published until October 2017. Studies were eligible for analysis if they compared patients with concomitant carcinoma in situ in radical cystectomy specimens for bladder cancer to patients without concomitant carcinoma in situ to determine its value to prognosticate overall mortality, recurrence-free survival, cancer specific mortality and ureteral involvement using multivariable analysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.05.162DOI Listing
January 2019
7 Reads

Fluorescence in situ hybridization microscopic detection of Bacilli Calmette Guérin mycobacteria in aortic lesions: A case report.

Medicine (Baltimore) 2018 Jul;97(30):e11321

Microbiology Laboratory.

Rationale: To improve the diagnosis of life-threatening Bacilli Calmette Guérin (BCG) arterial aneurysm in patients treated by intravesical instillation of BCG vaccine as adjunctive therapy for non-muscular bladder carcinoma, is a life-threatening condition. Its diagnosis remains cumbersome.

Patient Concerns: One patient with a history of intravesical BCG installation presented with aortic aneurysm with routine microscopic examination after Ziehl-Neelsen staining remaining negative. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000011321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078740PMC
July 2018
11 Reads

The effect of marital status on the survival of patients with bladder urothelial carcinoma: A SEER database analysis.

Medicine (Baltimore) 2018 Jul;97(29):e11378

Department of Urology, Subei People's Hospital of Jiangsu Province GClinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.

To identify whether marital status is associated with survival in patients with bladder urothelial carcinoma (UC). Using Surveillance, Epidemiology, and End Results population-based data, 133,846 patients diagnosed with bladder UC between 1988 and 2009 were identified. Kaplan-Meier methods and multivariable Cox regression models were used for survival analyses and evaluation of the association between marital status and survival, after controlling for gender, age, race, primary site, tumor (topography), lymph node, metastasis stage, pathological grading, and surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000011378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086512PMC
July 2018
2 Reads

FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients.

Clin Genitourin Cancer 2018 10 31;16(5):360-364. Epub 2018 May 31.

Department of Urology, University of Minnesota, Minneapolis, MN.

Purpose: To determine the accuracy of F-fluorodeoxyglucose with positron emission tomography and computed tomography (FDG-PET/CT) scans in assessing the response to neoadjuvant chemotherapy (NAC) in patients with bladder cancer scheduled to undergo radical cystectomy (RC).

Patients And Methods: All patients treated at our center for muscle-invasive bladder cancer (MIBC) were counseled and offered NAC before RC. FDG-PET/CT scans were performed before the initiation of chemotherapy and after completion of the regimen. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.05.008DOI Listing
October 2018
9 Reads

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.

Lancet 2018 06;391(10139):2525-2536

Department of Urology, Division of Urologic Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; CHRISTUS Santa Rosa Medical Center Hospital, San Antonio, TX, USA.

Background: Radical cystectomy is the surgical standard for invasive bladder cancer. Robot-assisted cystectomy has been proposed to provide similar oncological outcomes with lower morbidity. We aimed to compare progression-free survival in patients with bladder cancer treated with open cystectomy and robot-assisted cystectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)30996-6DOI Listing
June 2018
23 Reads

High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.

Urol Int 2018 4;101(1):7-15. Epub 2018 Jul 4.

Department of Urology, Medical University of Vienna, Vienna, Austria.

Introduction: The aim of this multicenter study was to investigate the prognostic impact of residual T1 high-grade (HG)/G3 tumors at re-transurethral resection (TUR of bladder tumor) in a large multi-institutional cohort of patients with primary T1 HG/G3 bladder cancer (BC).

Patients And Methods: The study period was from January 2002 to -December 2012. A total of 1,046 patients with primary T1 HG/G3 and who had non-muscle invasive BC (NMIBC) on re-TUR followed by adjuvant intravesical Bacillus Calmette-Guerin (BCG) therapy with maintenance were included. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/490765
Publisher Site
http://dx.doi.org/10.1159/000490765DOI Listing
January 2019
45 Reads

Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer.

Cell Physiol Biochem 2018 27;47(4):1565-1577. Epub 2018 Jun 27.

Department of Urology, the Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.

Background/aims: Emerging novel optical imaging techniques with cancer-specific molecular imaging agents offer a powerful and promising platform for cancer detection and resection. White-light cystoscopy and random bladder biopsies remain the most appropriate but nonetheless suboptimal diagnostic technique for bladder cancer, which is associated with high morbidity and recurrence. However, white-light cystoscopy has intrinsic shortcomings. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/490875
Publisher Site
http://dx.doi.org/10.1159/000490875DOI Listing
August 2018
19 Reads

[Usefulness of cold ureteral biopsy during radical cystectomy as a predictor of recurrence risk: Review of our series.]

Arch Esp Urol 2018 Jun;71(5):486-494

Servicio de Urología. Hospital Universitario Central de Asturias. Oviedo. Asturias. España.

Objectives: To evaluate the association of positive margins in the intraoperative biopsy during radical cystectomy (RC) with the risk of recurrence in the uretero-ileal anastomosis or upper urinary tract (UUT), and identify potential risk factors for positive ureteral margins.

Methods: A retrospective, descriptive study was performed in patients treated with radical cystectomy due to transitional cell carcinoma (TCC), who underwent a cold biopsy of the ureteral margin at the time of cystectomy. A descriptive analysis and frequency distribution was performed. Read More

View Article

Download full-text PDF

Source
June 2018
30 Reads

Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer.

Urol Oncol 2018 08 5;36(8):361.e7-361.e13. Epub 2018 Jun 5.

Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address:

Background: Reliable prognosticators for T1 bladder cancer (T1BC) are urgently needed.

Objective: To compare the prognostic value of 2 substage systems for T1BC in patients treated by transurethral resection (TUR) and adjuvant bacillus Calmette-Guérin therapy.

Design, Setting, And Participants: The slides of 601 primary T1BCs from four institutes were reviewed by 2 uropathologists and substaged according to 2 classifications: metric substage according to T1 microinvasive (T1m-lamina propria invasion <0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.05.007DOI Listing
August 2018
14 Reads

Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."

Urol Oncol 2018 07 5;36(7):345. Epub 2018 Jun 5.

Background: Carcinoma in situ (CIS) is a poor prognostic finding in urothelial carcinoma. However, its significance in muscle-invasive urothelial carcinoma (MIUC) treated with neoadjuvant chemotherapy (NAC) is uncertain. We assessed the effect of CIS found in pretreatment transurethral resection of bladder tumor (TURBT) biopsies on the pathologic and clinical outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.05.003DOI Listing
July 2018
14 Reads

Commentary on "A novel treatment strategy for newly diagnosed high-grade T1 bladder cancer: Gemcitabine and cisplatin adjuvant chemotherapy-A single-institution experience."

Urol Oncol 2018 07 30;36(7):346-347. Epub 2018 May 30.

Background: Management of high-grade T1 (formerly T1G3) bladder cancer continues to be controversial. Should patients with T1G3 bladder cancer have an immediate radical cystectomy or should they receive intravesical bacillus Calmette-Guérin preserving bladder? Gemcitabine and cisplatin (GC) adjuvant chemotherapy may help to strike a balance between intravesical and early cystectomy. For purposes of this study, we continue to refer high-grade T1 lesion as "T1G3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.05.012DOI Listing
July 2018
6 Reads

Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.

Urol Oncol 2018 08 30;36(8):361.e1-361.e6. Epub 2018 May 30.

University of Minnesota, Minneapolis, MN.

Introduction: Blue light cystoscopy (BLC) using hexaminolevulinate (HAL/Cysview/Hexvix) has been previously shown to improve detection of non-muscle-invasive bladder cancer (NMIBC). Herein, we evaluated the detection of malignant lesions in a heterogenous group of patients in the real world setting and documented the change in risk category due to upstaging or upgrading.

Methods: Prospective enrollment during April 2014 to December 2016 of consecutive adult patients with suspected or known non-muscle-invasive bladder cancer based on prior cystoscopy or imaging, undergoing transurethral resection of bladder tumor at 9 different referral medical centers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.04.013DOI Listing
August 2018
11 Reads

Salvage topical therapy for upper tract urothelial carcinoma.

World J Urol 2018 Dec 26;36(12):2027-2034. Epub 2018 May 26.

Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1373, Houston, TX, 77030, USA.

Purpose: Topical therapy (TT) for upper tract urothelial carcinoma (UTUC) has been explored as a kidney sparing approach to treat carcinoma in situ (CIS) and as adjuvant for endoscopically treated Ta/T1 tumors. In bladder cancer, data support use of salvage TT for repeat induction. We investigate the outcomes of salvage TT for UTUC in patients ineligible for or refusing nephroureterectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2349-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261784PMC
December 2018
6 Reads

Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.

Hum Pathol 2018 Sep 12;79:57-65. Epub 2018 May 12.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Electronic address:

Small cell carcinoma (SmCC) of the bladder is a rare disease. We retrospectively studied a large series of bladder SmCC from a single institution. The patients included 69 men and 12 women with a mean age of 68 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.05.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133751PMC
September 2018
36 Reads

miR-429 expression in bladder cancer and its correlation with tumor behavior and clinical outcome.

Kaohsiung J Med Sci 2018 Jun 2;34(6):335-340. Epub 2018 Mar 2.

Division of Urology, Department of Surgery, Tri-Service General Hospital, Taipei, Taiwan; Department of Surgery, National Defense Medical Center, Taipei, Taiwan. Electronic address:

We previously showed that microRNA-429 (miR-429) played an important role in epithelial-mesenchymal transition (EMT) of urothelial cell carcinoma of the bladder. We herein evaluated the expression of miR-429 in bladder cancer and its potential relevance to clinicopathological characteristics and patient survival. Relative expression levels of miR-429 in surgical bladder cancer tissue specimens obtained from 76 patients with bladder cancer were measured by chromogenic in situ hybridization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kjms.2018.01.001DOI Listing
June 2018
3 Reads

Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors.

Medicine (Baltimore) 2018 Apr;97(16):e0522

Department of Urology, University of Medicine and Pharmacy, Tirgu Mures, Romania.

To compare long-term overall survival (OS) in patients with G1 and G2 grade Ta bladder cancer after transurethral resection of bladder tumors (TURBTs). Secondary aim was to investigate clinical and pathologic prognostic factors for OS of Ta patients, except G3/high grade (HG).A total of 243 patients, retrospectively selected, with Ta nonmuscle invasive bladder cancer (NMIBC) underwent TURBT between January 2006 and December 2008 (median follow-up 109 months). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000010522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916673PMC
April 2018
29 Reads